Abstract
Purpose. To establish and characterize a choroid plexus epithelial cell line (TR-CSFB) from a new type of transgenic rat harboring the temperature-sensitive simian virus 40 (ts SV 40) large T-antigen gene (Tg rat).
Methods. Choroid plexus epithelial cells were isolated from the Tg rat and cultured on a collagen-coated dish at 37°C during the first period of 3 days. Cells were subsequently cultured at 33°C to activate large T-antigen. At the third passage, cells were cloned by colony formation and isolated from other cells using a penicillin cup.
Results. Five immortalized cell lines of choroid plexus epithelial cells (TR-CSFB 1∼5) were obtained from two Tg rats. These cell lines had a polygonal cell morphology, expressed the typical choroid plexus epithelial cell marker, transthyretin, and possessed Na+, K+-ATPase on their apical side. TR-CSFBs cells expressed a large T-antigen and grew well at 33°C with a doubling-time of 35∼40 hr. [3H]-L-Proline uptake by TR-CSFB cells took place in an Na+-dependent, ouabain-sensitive, energy-dependent, and concentration-dependent manner. It was also inhibited by α-methylaminoisobutylic acid, suggesting that system A for amino acids operates in TR-CSFB cells. When [3H]-L-proline uptake was measured using the Transwell device, the L-proline uptake rate following application to the apical side was fivefold greater than that following application to the basal side. In addition, both Na+-dependent and Na+-independent L-glutamic acid (L-Glu) uptake processes were present in TR-CSFB cells.
Conclusions. Immortalized choroid plexus epithelial cell lines were successfully established from Tg rats and have the properties of choroid plexus epithelial cells, and amino acid transport activity was observed in vivo.
Similar content being viewed by others
REFERENCES
X. Wu, L. R. Whitfield, and B. H. Stewart. Atovastatin transport in the Caco-2 cell model: Contributions of P-glycoprotein and proton-monocarboxylic acid co-transporter. Pharm. Res. 17:209-215 (2000).
A. Soldner, L. Z. Benet, E. Mutschler, and U. Christians. Active transport of the angiotensin-II antagonist losartan and its main metabolite EXP 3174 across MDCK-MDR1 and Caco-2 cell monolayers. Br. J. Pharmacol. 129:1235-1243 (2000).
J. D. Irvine, L. Takahashi, K. Lockhart, J. Cheong, J. W. Tolen, H. E. Selick, and J. R. Grove. MDCK (Madin-Darby canine kidney) cells: A tool for membrane permeability screening. J. Pharm. Sci. 88:28-33 (1999).
R. Spector and C. E. Johanson. The mammalian choroid plexus. Sci. Am. 261:48-53 (1989).
Y. Sugiyama, H. Kusuhara, and H. Suzuki. Kinetic and biochemical analysis of carrier-mediated efflux of drugs through the blood-brain and blood-cerebrospinal fluid barriers: importance in the drug delivery to the brain. J. Control. Rel. 62:179-186 (1999).
S. A. Klarr, L. J. Ulanski, W. Stummer, J. Xiang, A. L. Betz, and R. F. Keep. The effects of hypo-and hyperkalemia on a choroids plexus potassium transport. Brain Res. 758:39-44 (1997).
T. Kitazawa, K. Hosoya, T. Takahashi, Y. Sugiyama, and T. Terasaki. In-vivo and in-vitro evidence of a carrier-mediated efflux transport system for oestrone-3-sulphate across the blood-cerebrospinal fluid barrier. J. Pharm. Pharmacol. 52:281-288 (2000).
V. K. Ramanathan, A. C. Hui, C. M. Brett, and K. M. Giacomini. Primary cell culture of the rabbit choroid plexus: An experimental system to investigate membrane transport. Pharm. Res. 13:952-956 (1996).
A. R. Villalobous, J. T. Parmelee, and J. B. Pritchard. Functional characterization of choroid plexus epithelial cells in primary culture. J. Pharmacol. Exp. Ther. 282:1109-1116 (1997).
W. Zheng, Q. Zhao, and J. H. Graziano. Primary culture of choroidal epithelial cells: characterization of an in vitro model of blood-CSF barrier. In Vitro Cell Dev. Biol-Animal. 34:40-45 (1998).
R. Takahashi, M. Hirabayashi, N. Yanai, M. Obinata, and M. Ueda. Establishment of SV40-tsA58 transgenic rats as a source of conditionally immortalized cell lines. Exp. Anim. 48:255-261 (1999).
M. Obinata. Conditionally immortalized cell lines with differentiated functions established from temperature-sensitive T-antigen transgenic mice. Genes Cells 2:235-244 (1997).
C. B. Washington, K. M. Giacomini, and C. M. Brett. Method to study drug transport in isolated choroids plexus tissue and cultured cells. In R. T. Borchardt, P. L. Smith, and G. Wilson (eds.), Models for assessing drug absorption and metabolism Plenum Press, New York, 1996, pp. 259-283.
K. Yamaoka, Y. Tanigawara, T. Nakagawa, and T. Uno. A pharmacokinetic analysis program (MULTI) for microcomputer. J. Pharmacobio-Dyn. 4:879-885 (1981).
Y. Gluzman. SV40-transformed simian cells support the replication of early SV40 mutants. Cell 23:175-182 (1981).
J. Herbert, J. K. Wilcox, and K. C. Pham. Transthyretin: A choroid plexus-specific transport protein in human brain. Neurology 36:900-911 (1986).
L. J. Rizzolo. Polarity and the development of the outer blood-retinal barrier. Histol. Histopathol. 12:1057-1067 (1997).
L. A. Coben, E. Cotlier, C. Beaty, and B. Becker. Transport of amino acids by rabbit choroid plexus in vitro. Brain Res. 30:67-82 (1971).
P. S. R. Norman and G. E. Mann. Transport characteristics of system A in the rat exocrine pancreatic epithelium analyzed using the specific non-metabolized amino acid analogue α-methylaminoisobutyric acid. Biochim. Biophys. Acta 861:389-394 (1986).
Q. R. Smith and J. Stoll. Blood-brain barrier amino acid transport. In W. M. Pardridge (ed.), Introduction to the blood-brain barrier, Cambridge University Press, Cambridge, 1998, pp. 188-197.
R. T. Fremeau Jr., M. V. Faircloth, J. W. Miller, V. A. Henzi, S. M. Cohen, J. V. Nadler, S. Shafqat, R. D. Blakely, and B. Domin. A nobel nonopioid action of enkephalins: Competitive inhibition of the mammalian brain high affinity L-proline transporter. Mol. Pharmacol. 49:1033-1041 (1996).
T. Kruse, H. Reiber, and V. Neuhoff. Amino acid transport across the human blood-CSF barrier. J. Neurol. Sci. 70:129-138 (1985).
Y. Yoneda and E. Roberts. A new synaptosomal biosynthetic pathway of proline from ornithine and its negative feedback inhibition by proline. Brain Res. 239:479-788 (1982).
J. E. Nadler, A. Wang, and A. Hakim. Toxicity of L-proline toward rat hippocampal neurons. Brain Res. 456:168-172 (1988).
S. M. Cohen and J. V. Nadler. Proline-induced potentiation of glutamate transmission. Brain Res. 761:271-282 (1997).
C. S. Kim, A. Virella, R. C. Braunberg, I. A. Ross, R. N. Matthews, W. Johnson, and L. Friedman. Kinetic analysis of glutamate transport by the miniswine choroid plexus in vitro. Brain Res. 709:59-64 (1996).
P. J. Shaw, V. Forrest, P. G. Ince, J. P. Richardson, and H. J. Wastell. CSF and plasma amino acid levels in motor neuron disease: elevation of CSF glutamate in a subset of patients. Neurodegeneration 4:209-216 (1995).
K. Kanai. Family of neutral and acidic amino acid transporters: Molecular biology and medical implications. Curr. Opin. Cell Biol. 9:565-572 (1997).
M. B. Segal, J. E. Preston, C. S. Collis, and B. V. Zlokovic. Kinetics and Na independence of amino acid uptake by blood side of perfused sheep choroids plexus. Am. J. Physiol. 258:F1288-F1294 (1989).
H. Sato, M. Tamba, T. Ishii, and S. Bannai. Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins. J. Biol. Chem. 274:11455-11458 (1999).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kitazawa, T., Hosoya, Ki., Watanabe, M. et al. Characterization of the Amino Acid Transport of New Immortalized Choroid Plexus Epithelial Cell Lines: A Novel In Vitro System for Investigating Transport Functions at the Blood-Cerebrospinal Fluid Barrier. Pharm Res 18, 16–22 (2001). https://doi.org/10.1023/A:1011014424212
Issue Date:
DOI: https://doi.org/10.1023/A:1011014424212